[The radionuclide diagnosis of vasorenal hypertension using an angiotensin-converting enzyme inhibitor]. 1994

A F Vozianov, and A Iu Shcherbak, and P P Prishchepa, and V I Zubko, and R V Guts, and A S Sabadash

Conventional routine renography and dynamic renoscintigraphy fail to yield sufficient diagnostic criteria in vasorenal hypertension, being associated with 21.5% false negative and 33.3% false positive results. Capoten induces statistically significant functional changes manifested by worsening of time-associated indicators of secretory-excretory function of the kidney, glomerular filtration rate and effective renal plasma flow on the side of the unilateral renal artery stenosis; relative hypotension in this situation leads to a statistically insignificant improvement of functional activity of the contralateral kidney parenchyma.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D006978 Hypertension, Renovascular Hypertension due to RENAL ARTERY OBSTRUCTION or compression. Hypertension, Goldblatt,Goldblatt Syndrome,Goldblatt Hypertension,Renovascular Hypertension,Syndrome, Goldblatt
D007465 Iodohippuric Acid An iodine-containing compound used in pyelography as a radiopaque medium. If labeled with radioiodine, it can be used for studies of renal function. Iodobenzoylglycine,Sodium Iodohippurate,I-Hippuran,I-OIH,Orthoiodohippurate,Radio-Hippuran,Sodium o-Iodohippurate,ortho-Iodohippurate,Acid, Iodohippuric,I Hippuran,I OIH,Iodohippurate, Sodium,Radio Hippuran,RadioHippuran,Sodium o Iodohippurate,o-Iodohippurate, Sodium,ortho Iodohippurate
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011866 Radioisotope Renography Graphic tracing over a time period of radioactivity measured externally over the kidneys following intravenous injection of a radionuclide which is taken up and excreted by the kidneys. Renography,Radioisotope Renographies,Renographies,Renographies, Radioisotope,Renography, Radioisotope
D012078 Renal Artery Obstruction Narrowing or occlusion of the RENAL ARTERY or arteries. It is due usually to ATHEROSCLEROSIS; FIBROMUSCULAR DYSPLASIA; THROMBOSIS; EMBOLISM, or external pressure. The reduced renal perfusion can lead to renovascular hypertension (HYPERTENSION, RENOVASCULAR). Renal Artery Stenosis,Obstruction, Renal Artery,Obstructions, Renal Artery,Renal Artery Obstructions,Renal Artery Stenoses,Stenoses, Renal Artery,Stenosis, Renal Artery
D002216 Captopril A potent and specific inhibitor of PEPTIDYL-DIPEPTIDASE A. It blocks the conversion of ANGIOTENSIN I to ANGIOTENSIN II, a vasoconstrictor and important regulator of arterial blood pressure. Captopril acts to suppress the RENIN-ANGIOTENSIN SYSTEM and inhibits pressure responses to exogenous angiotensin. (S)-1-(3-Mercapto-2-methyl-1-oxopropyl)-L-proline,Capoten,Lopirin,SQ-14,225,SQ-14,534,SQ-14225,SQ-14534,SQ 14,225,SQ 14,534,SQ 14225,SQ 14534,SQ14,225,SQ14,534,SQ14225,SQ14534
D005919 Glomerular Filtration Rate The volume of water filtered out of plasma through glomerular capillary walls into Bowman's capsules per unit of time. It is considered to be equivalent to INULIN clearance. Filtration Rate, Glomerular,Filtration Rates, Glomerular,Glomerular Filtration Rates,Rate, Glomerular Filtration,Rates, Glomerular Filtration
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

A F Vozianov, and A Iu Shcherbak, and P P Prishchepa, and V I Zubko, and R V Guts, and A S Sabadash
August 1978, The New England journal of medicine,
A F Vozianov, and A Iu Shcherbak, and P P Prishchepa, and V I Zubko, and R V Guts, and A S Sabadash
February 1979, Angiology,
A F Vozianov, and A Iu Shcherbak, and P P Prishchepa, and V I Zubko, and R V Guts, and A S Sabadash
January 1989, Clinical therapeutics,
A F Vozianov, and A Iu Shcherbak, and P P Prishchepa, and V I Zubko, and R V Guts, and A S Sabadash
November 1979, British medical journal,
A F Vozianov, and A Iu Shcherbak, and P P Prishchepa, and V I Zubko, and R V Guts, and A S Sabadash
December 1978, Schweizerische medizinische Wochenschrift,
A F Vozianov, and A Iu Shcherbak, and P P Prishchepa, and V I Zubko, and R V Guts, and A S Sabadash
May 1981, British journal of clinical pharmacology,
A F Vozianov, and A Iu Shcherbak, and P P Prishchepa, and V I Zubko, and R V Guts, and A S Sabadash
June 1975, Clinical science and molecular medicine. Supplement,
A F Vozianov, and A Iu Shcherbak, and P P Prishchepa, and V I Zubko, and R V Guts, and A S Sabadash
January 1993, Cor et vasa,
A F Vozianov, and A Iu Shcherbak, and P P Prishchepa, and V I Zubko, and R V Guts, and A S Sabadash
January 1974, Terapevticheskii arkhiv,
A F Vozianov, and A Iu Shcherbak, and P P Prishchepa, and V I Zubko, and R V Guts, and A S Sabadash
September 1991, Nihon rinsho. Japanese journal of clinical medicine,
Copied contents to your clipboard!